NEW YORK (GenomeWeb News) – Arcxis Biotechnologies said today that it will collaborate with Roche Molecular Systems, a business area of Roche Diagnostics, on sample-preparation technology for molecular diagnostics.
Under the collaboration, Arcxis will use its proprietary total RNA and genomic DNA isolation and concentration technology with PCR and RT-PCR-based diagnostic tests. The company expects that its methods for preparing blood and tissue will produce “significant performance benefits” for PCR-based tests.